Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Steven Rosen

Steven Rosen


Academic history

Steven Rosen is the Provost and Chief Scientific Officer of the City of Hope National Medical Center, Duarte, CA, and leads the Beckman Research Institute at City of Hope Duarte, CA, and the Irell & Manella Graduate School of Biological Sciences, Duarte, CA.

Prof. Rosen received his medical degree from the Northwestern University Medical School, Chicago, IL, and subsequently completed a residency in internal medicine at Northwestern Memorial Hospital, Chicago, IL, and a fellowship in hematology/oncology at the National Cancer Institute, Bethesda, MD. Prior to joining City of Hope, Prof. Rosen was the Director at The Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and the Genevieve Teuton Professor of Medicine at the Feinberg School of Medicine at Northwestern University.

Speaking on leukemia, lymphoma, and multiple myeloma

Prof. Rosen is an expert in the diagnosis and treatment of blood cancers, particularly non-Hodgkin lymphoma, cutaneous T-cell lymphoma (CTCL), chronic lymphocytic leukemia and multiple myeloma. His research has previously investigated the role of proteins in cancer metabolism and the use of RNA-directed nucleoside analogs in cancer therapy.

Prof. Rosen has recently been involved in investigating new targets for various blood cancers. His research includes developing novel p38γ inhibitors targeting (CTCL), as well as targeting c-Myc and proteasome inhibitor resistance in myeloma, where the oncogene c-Myc is a key driver.